Whereas DOT1L interacts with MLL oncogenic fusion proteins, such as AF4, ENL, ELL, and AF1012,13 to activate a proliferative transcriptional program in leukemia cells, in melanocytes, DOT1L interacts with XPC to facilitate DNA repair and prevent melanoma development. This evidence concerns the gene KMT2A and melanoma.